The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Open accessAbstract
Summary We screened 124 genes that are amplified in human HCC using a mouse hepatoblast model and identified 18 tumor-promoting genes, including CCND1 and its neighbor on 11q13.3, FGF19. Although it is widely assumed that CCND1 is the main driving oncogene of this common amplicon (15% frequency in HCC), both forward-transformation assays and RNAi-mediated inhibition in human HCC cells established that FGF19 is an equally important driver gene in HCC. Furthermore, clonal growth and tumorigenicity of HCC cells harboring the 11q13.3 amplicon were selectively inhibited by RNAi-mediated knockdown of CCND1 or FGF19, as well as by an anti-FGF19 antibody. These results show that 11q13.3 amplification could be an effective biomarker for patients most likely to respond to anti-FGF19 therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Self-citationChromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
Weinstein, I. B., & Joe, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3293 · Cited by 805
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
A human functional protein interaction network and its application to cancer data analysis
Wu, G., Feng, X., & Stein, L. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-r53 · Cited by 692
Self-citationHudziak, R. M., Schlessinger, J., & Ullrich, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7159 · Cited by 625
(2004) · Genome Research · doi:10.1101/gr.2596504 · Cited by 577
Lucito, R., Healy, J., Alexander, J., Reiner, A., Esposito, D., Chi, M., Rodgers, L., Brady, A., Sebat, J., Troge, J., et al. (2003) · Genome Research · doi:10.1101/gr.1349003 · Cited by 441
Self-citationHigh-resolution genomic profiles of human lung cancer
Tonon, G., Wong, K.-K., Maulik, G., Brennan, C., Feng, B., Zhang, Y., Khatry, D. B., Protopopov, A., You, M. J., Aguirre, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504126102 · Cited by 394
A Mouse Model of Hepatocellular Carcinoma
Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J.-P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61177-7 · Cited by 359
Self-citationTargeting of tetraspanin proteins — potential benefits and strategies
Hemler, M. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2659 · Cited by 345
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
Fox, C. J., Hammerman, P. S., Cinalli, R. M., Master, S. R., Chodosh, L. A., & Thompson, C. B. (2003) · Genes & Development · doi:10.1101/gad.1105003 · Cited by 336
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
Schwab, M., Varmus, H. E., & Bishop, J. M. (1985) · Nature · doi:10.1038/316160a0 · Cited by 288
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Desnoyers, L. R., Pai, R., Ferrando, R. E., Hötzel, K., Le, T., Ross, J., Carano, R., D'Souza, A., Qing, J., Mohtashemi, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210623 · Cited by 264
Self-citationGenomic amplification and oncogenic properties of the KCNK9 potassium channel gene
Mu, D., Chen, L., Zhang, X., See, L.-H., Koch, C. M., Yen, C., Tong, J. J., Spiegel, L., Nguyen, K. C. Q., Servoss, A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00054-0 · Cited by 263
Self-citationHer-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
Pegram, M. D., Pauletti, G., & Slamon, D. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006111117877 · Cited by 259
Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer
Kendall, J., Liu, Q., Bakleh, A., Krasnitz, A., Nguyen, K. C. Q., Lakshmi, B., Gerald, W. L., Powers, S., & Mu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708286104 · Cited by 236
Self-citationRNA polymerases I and III, non-coding RNAs and cancer
White, R. J. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.10.003 · Cited by 190
FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
Wu, X., Ge, H., Lemon, B., Vonderfecht, S., Weiszmann, J., Hecht, R., Gupte, J., Hager, T., Wang, Z., Lindberg, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068783 · Cited by 183
Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
Deane, N. G., Parker, M. A., Aramandla, R., Diehl, L., Lee, W. J., Washington, M. K., Nanney, L., Shyr, Y., & Beauchamp, R. D. (2001) · PubMed · Cited by 180
Roles of Pofut1 and O-Fucose in Mammalian Notch Signaling
Stahl, M., Uemura, K., Ge, C., Shi, S., Tashima, Y., & Stanley, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802027200 · Cited by 176
The Wnt/β-Catenin→Pitx2 Pathway Controls the Turnover of Pitx2 and Other Unstable mRNAs
Briata, P., Ilengo, C., Corte, G., Moroni, C., Rosenfeld, M. G., Chen, C.-Y., & Gherzi, R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00407-6 · Cited by 163
Gordon, M. S., Sweeney, C. J., Mendelson, D. S., Eckhardt, S. G., Anderson, A., Beaupre, D. M., Branstetter, D., Burgess, T. L., Coxon, A., Deng, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1365 · Cited by 162
Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma
Huang, J.-S., Chao, C., Su, T.-L., Yeh, S., Chen, D., Chen, C., Chen, P., & Jou, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.151 · Cited by 145
Pathogenesis of hepatocellular carcinoma and molecular therapies
Mínguez, B., Tovar, V., Chiang, D. Y., Villanueva, A., & Llovet, J. M. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32832962a1 · Cited by 140
Huang, X., Godfrey, T. E., Gooding, W. E., McCarty, K. S., & Gollin, S. M. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20371 · Cited by 138
Podsypanina, K., Politi, K. A., Beverly, L. J., & VARMUS, H. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801197105 · Cited by 126
Genetics of hepatocellular carcinoma
Teufel, A., Staib, F., Kanzler, S., Weinmann, A., Schulze-Bergkamen, H., & Galle, P.-R. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i16.2271 · Cited by 126
Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating β-Catenin Signaling
Pai, R., Dunlap, D. Y., Qing, J., Mohtashemi, I., Hötzel, K., & French, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2325 · Cited by 125
Self-citationGene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer
Fantl, V., Richards, M. A., Smith, D., Lammie, G. A., Johnstone, G., Allen, D., Gregory, W. M., Peters, G., Dickson, C., & Barnes, D. M. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90009-i · Cited by 114
Azechi, H., Nishida, N., Fukuda, Y., Nishimura, T., Minata, M., Katsuma, H., Kuno, M., Ito, T., Komeda, T., Kita, R., et al. (2001) · Oncology · doi:10.1159/000058531 · Cited by 111
The Right to Choose: Multiple Pathways for Activating Copper,Zinc Superoxide Dismutase
Leitch, J. M., Yick, P. J., & Culotta, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.040410 · Cited by 111
Cyclin D1 Is Not an Immediate Target of β-Catenin following Apc Loss in the Intestine
Sansom, O. J., Reed, K. R., van de Wetering, M., Muncan, V., Winton, D. J., Clevers, H. C., & Clarke, A. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500191200 · Cited by 111
Lavoie, J. N., Rivard, N., L’Allemain, G., & Pouysségur, J. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_5 · Cited by 106
Sandilands, E., Brunton, V. G., & Frame, M. C. (2007) · Journal of Cell Science · doi:10.1242/jcs.003657 · Cited by 99
Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
Woo, H. G., Park, E. S., Lee, J., Lee, Y.-H., Ishikawa, T., Kim, Y. J., & Thorgeirsson, S. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0164 · Cited by 96
Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma
Okami, K., Reed, A. L., Cairns, P., Koch, W. M., Westra, W. H., Wehage, S. L., Jen, J., & Sidransky, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202837 · Cited by 84
The cyclin D1b splice variant: an old oncogene learns new tricks.
Knudsen, K. E. (2006) · Cell Division · doi:10.1186/1747-1028-1-15 · Cited by 79
Zender, L., Xue, W., Cordon‐Cardo, C., Hannon, G. J., Lucito, R., Powers, S., Flemming, P., Spector, M. S., & Lowe, S. W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.059 · Cited by 69
Self-citationGibcus, J. H., Kok, K., Menkema, L., Hermsen, M. A. J. A., Mastik, M. F., Kluin, P. M., van der Wal, J. E., & Schuuring, E. M. D. (2006) · Human Genetics · doi:10.1007/s00439-006-0299-6 · Cited by 45
Differences underlying EGFR and HER2 oncogene addiction
Faber, A. C., Wong, K., & Engelman, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.5.11096 · Cited by 41
Gong, J.-P., Wang, J.-J., Ren, K., Liu, C.-A., Li, B., & Shi, Y.-J. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.03.033 · Cited by 36
Matthews, C. C., Figueiredo, D. M. M., Wollack, J. B., Fairweather, N. F., Gordon Dougan, B., Hallewell, R. A., Cadet, J. L., & Fishman, P. S. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:3:155 · Cited by 10
Cited by
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, J. M., Montal, R., Sia, D., & Finn, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0073-4 · Cited by 1,938
Self-citationSchulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Metadata
- Authors
- Sawey, E. T., Chanrion, M., Cai, C., Wu, G., Zhang, J., Zender, L., Zhao, A., Busuttil, R. W., Yee, H., Stein, L., French, D. M., Finn, R. S., Lowe, S. W., & Powers, S.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 19
- Issue
- 3
- Pages
- 347-358
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2095943598
- Cited by
- 436
- References
- 48
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.